HBIO — Harvard Bioscience Share News
0.000.00%
Last trade - 00:00- $37.83m
- $68.01m
- $86.55m
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Harvard Bioscience Q4 revenue falls 3%, reports net loss
Brief: Harvard Bioscience Announces Reverse Stock Split
Brief: Harvard Bioscience Announces The Successful Completion Of Debt Refinancing
Brief: Harvard Bioscience Enters Loan Agreement With Some Lenders
Harvard Bioscience Q3 revenue beats estimates, net loss narrows
Brief: Harvard Bioscience Q3 Revenue USD 20.591 Million
Brief: Harvard Bioscience Granted 180 Days For Compliance - SEC Filing
Brief: Harvard Bioscience Appoints Stephen Denelsky To Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue meet estimates